# Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer

> **NCT00002562** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 25 (estimated)

## Conditions studied

- Cervical Cancer
- Vaginal Cancer

## Interventions

- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00002562
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-03
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002562, "Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*